Publication:
Recommendations for kidney patients in covid-19 era based on current evidence

dc.contributor.authorVELİOĞLU, ARZU
dc.contributor.authorTUĞLULAR, ZÜBEYDE SERHAN
dc.contributor.authorsOzturk S., VELİOĞLU A., TUĞLULAR Z. S.
dc.date.accessioned2023-04-03T10:27:53Z
dc.date.available2023-04-03T10:27:53Z
dc.date.issued2022-01-01
dc.description.abstractPatients with chronic kidney disease, patients on dialysis, and kidney transplant recipients are at high risk of mortality and morbidity due to coronavirus disease-19. Most patients with chronic kidney disease are elderly and have other comorbidities. In addition, some of these patients have been exposed to immunosuppressive drugs to treat their underlying primary disease or to prevent allograft rejection. This general profile of chronic kidney disease patients renders them susceptible to a more severe course of coronavirus disease-19 once they are infected with severe acute respiratory syndrome coronavirus 2. Many studies showed that impaired kidney function on admission is an independent risk factor for a more severe course of coronavirus disease-19 with significantly increased risk for hospital and intensive care unit admission, intubation, mechanical ventilation, and death. Coronavirus disease-19 vaccination is crucial to create immunity in the general community, but the evidence addressing this specific population is scarce. However, based on the current evidence, all patients with chronic kidney disease are strongly recommended to receive the available vaccine in their country against coronavirus disease-19, and booster doses will presumably prove necessary for this group of patients. Furthermore, vigilant use of protective measures is strongly recommended for this patient population. Current studies and recommendations from health authorities should be followed closely.
dc.identifier.citationOzturk S., VELİOĞLU A., TUĞLULAR Z. S., "Recommendations for Kidney Patients in COVID-19 Era Based on Current Evidence", TURKISH JOURNAL OF NEPHROLOGY, cilt.31, sa.1, ss.7-16, 2022
dc.identifier.doi10.5152/turkjnephrol.2022.21234
dc.identifier.endpage16
dc.identifier.issn2667-4440
dc.identifier.issue1
dc.identifier.startpage7
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/532388/recommendations-for-kidney-patients-in-covid-19-era-based-on-current-evidence
dc.identifier.urihttps://hdl.handle.net/11424/288111
dc.identifier.volume31
dc.relation.ispartofTURKISH JOURNAL OF NEPHROLOGY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.subjectMedicine
dc.subjectHealth Sciences
dc.subjectInternal Medicine Sciences
dc.subjectInternal Diseases
dc.subjectNephrology
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectUROLOGY & NEPHROLOGY
dc.subjectCLINICAL MEDICINE
dc.subjectClinical Medicine (MED)
dc.subjectUrology
dc.subjectClinical nephrology
dc.subjectCOVID-19
dc.subjecthemodialysis
dc.subjectperitoneum dialysis
dc.subjectkidney transplantation
dc.subjectDIALYSIS PATIENTS
dc.subjectTRANSPLANT
dc.subjectMORTALITY
dc.subjectVACCINATION
dc.subjectINFECTION
dc.subjectRESPONSES
dc.subjectTHERAPY
dc.subjectDISEASE
dc.titleRecommendations for kidney patients in covid-19 era based on current evidence
dc.typearticle
dspace.entity.typePublication
local.avesis.id5e2d66f1-fe06-4f0b-86d7-df23775ec39e
local.indexed.atWOS
local.indexed.atSCOPUS
local.indexed.atTRDIZIN
relation.isAuthorOfPublicationa7410f0e-0eb4-4b83-ad61-a71dfbee164f
relation.isAuthorOfPublication3ea0c6f9-3408-46b6-b382-144ccbf7bc72
relation.isAuthorOfPublication.latestForDiscoverya7410f0e-0eb4-4b83-ad61-a71dfbee164f

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
20.pdf
Size:
913.03 KB
Format:
Adobe Portable Document Format

Collections